По вашему запросу найдено документов: 97

Страница 1 из 10

LncRNA as potential biomarker and therapeutic target in glioma
Xun, Xu,, Liang, Yuan, Gareev, Ilgiz, Liang, Yanchao, Liu, Rui, Wang, Ning, Yang, Guang (2023)
and chemoradiotherapy resistance, we discussed the feasibility for lncRNAs as therapeutic targets. Finally
THE ROLE OF LONG NONCODING RNAS IN THE BIOLOGY OF PITUITARY ADENOMAS
BEILERLI, O.A., GAREEV, I.F., V.N. Pavlov, CHEN, X., ZHAO, S. (2020)
the therapeutic possibilities for pituitary adenomas.
SIGNALING PATHWAYS AND THERAPEUTIC APPROACHES IN GLIOBLASTOMA MULTIFORME (REVIEW)
KHABIBOV, M., GARIFULLIN, A., KHAMITOV, F., KHALIKOVA, L., BOUMBER, Y., KHADDOUR, K., FERNANDEZ, M., KUZNETSOVA, N., KIT, O., KHARIN, L. (2022)
into the processes of glioblastoma pathogenesis and the discovery of novel therapeutic targets in novel signaling
PATHOPHYSIOLOGY OF CALCIUM MEDIATED VENTRICULAR ARRHYTHMIAS AND NOVEL THERAPEUTIC OPTIONS WITH FOCUS ON GENE THERAPY
Paar, V., Jirak, P., Larbig, R., Zagidullin, N.S., Brandt, M.C., Lichtenauer, M., Hoppe, U.C., Motloch, L.J. (2019)
promising targets for suppression of ventricular arrhythmias. Accordingly, we report the different roles
Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis
Yanchao, L., Sibin, Z., Gareev, I., Huan, X., Junfei, Z., Chunyang, L., Beylerli, O., Sufianov, A., Chao, Y., Yuyan, G., Xun, X., Ahmad, A. (2022)
therapeutic agents for COVID-19 -infected patients with carotid atherosclerosis are also proposed. Conclusions
Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2
Yang, L., Luo, W., Zhang, Q, Hong, S., Wang, Y., Samorodov, A.V., Chattipakorn, N., Pavlov, V.N., Liang, G. (2021)
anti-inflammatory compounds for therapeutic target discovery and ALI treatment. Methods: 165 natural
Long non-coding RNAs in oncourology
Gareev, I, Gileva, Y, Dzidzaria, A, Beylerli, O, Pavlov, V, Agaverdiev, M, Mazorov, B, Biganyakov, I, Vardikyan, A, Jin, M, Ahmad, A (2021)
choice. Therefore, the possibility that lncRNAs could represent innovative therapeutic agents or targets
Mirnas as noninvasive biomarkers and therapeutic agents of pituitary adenomas
BEYLERLI, OZAL, BEERAKA, NARASIMHA M., GAREEV, ILGIZ, PAVLOV, VALENTIN, YANG, GUANG, LIANG, YANCHAO, ALIEV, GJUMRAKCH (2020)
single-stranded RNA molecules that can influence post-transcriptional regulation by controlling target
Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation
Qian, J., Zhuang, F., Chen, Y., Fan, X., Wang, J., Wang, Z., Wang, Y., Xu, M., Samorodov, A.V., Pavlov, V.N., Liang, G. (2022)
in DCM and to test the therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
TARGETING LNCDACH1 PROMOTES CARDIAC REPAIR AND REGENERATION AFTER MYOCARDIUM INFARCTION
CAI, B., MA, W., WANG, X., SUKHAREVA, N., HUA, B., ZHANG, L., LI, X., LI, S., LIU, S., YU, M., XU, Y., SONG, R., XU, B., YANG, F., HAN, Z., DING, F., HUANG, Q., YU, Y., ZHAO, Y., WANG, J., BAMBA, D., PAN, Z., YANG, B., XU, J., ZAGIDULLIN, N., LI, F., TIAN, Y. (2020)
DACH1 silencing-induced cardiomyocyte proliferation. In addition, targeting a conserved fragment of Lnc

Страница 1 из 10

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год